STAT

Teva reaches $85 million settlement on eve of opioid trial in Oklahoma

On the eve of a closely watched trial, Teva agreed to pay $85 million to settle charges made by the state of Oklahoma of fueling the opioid crisis by overstating…
A Teva Pharmaceutical facility building in Neot Hovav, Israel. Source: Tsafrir Abayov/AP

On the eve of a closely watched trial, Teva Pharmaceutical () agreed to pay $85 million to settle charges made by the state of Oklahoma of fueling the opioid crisis by overstating the benefits of its opioid painkillers and downplaying addictive risks that led doctors to

You're reading a preview, sign up to read more.

More from STAT

STAT4 min read
How The Drug Industry Keeps Winning In Washington
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. What if I told you the Sen. Thom Tillis campaign account was graced with nearly $20,000 in personal donations f
STAT5 min read
In A Small Study, A Cancer Vaccine Assist Beats Immunotherapy Drugs Alone
The largest study to date of a "cancer vaccine" found that combining it with an immunotherapy drug kept patients’ tumors in check longer, on average, than the drug alone.
STAT4 min readScience
HIV’s Genetic Code, Extracted From A Nub Of Tissue, Adds To Evidence Of Virus’ Emergence In Humans A Century Ago
In a nub of issue from the 1960s, scientists have found more clues of HIV’s emergence in humans.